AGAT Inhibitors

AGAT inhibitors belong to a specific chemical class of compounds that are designed to target and modulate the activity of the enzyme arginine glycine amidinotransferase (AGAT). This class of inhibitors is primarily focused on regulating the biochemical processes involved in creatine synthesis within the human body. AGAT is a crucial enzyme in the creatine biosynthesis pathway, playing a pivotal role in the conversion of arginine and glycine into guanidinoacetate, an intermediate metabolite in the formation of creatine. Creatine is an essential molecule involved in energy metabolism, particularly in tissues with high energy demands, such as skeletal muscles and the brain.

AGAT inhibitors involves the selective binding and inhibition of AGAT enzyme activity, thereby reducing the production of guanidinoacetate and ultimately leading to decreased creatine synthesis. By targeting AGAT, these inhibitors can potentially regulate creatine levels in the body, impacting cellular energy reserves and various physiological processes reliant on creatine. AGAT inhibitors have garnered interest in research settings, with the potential to explore their effects on creatine metabolism and their implications for conditions related to energy homeostasis and muscle function.